HLB Therapeutics Co.,Ltd.
115450
주식 순위
#18716
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
주가
$1.88
시가총액
$177.26M
변동 (1일)
-0.73%
변동 (1년)
-6.17%
국가
KR
거래 HLB Therapeutics Co.,Ltd. (115450)
카테고리
Healthcare
의 시가총액 HLB Therapeutics Co.,Ltd.(115450)
시가총액: $177.26M
October 2026 기준으로 HLB Therapeutics Co.,Ltd.의 시가총액은 $177.26M입니다. 이는 당사 데이터에 따르면 HLB Therapeutics Co.,Ltd.이 세계에서 18716th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2010부터 2026까지 HLB Therapeutics Co.,Ltd.의 시가총액 기록
115450 가장 인기있는 상위 5 가지 stocks과 비교하여
